BiotechTube

EscharEx + Gel Vehicle

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hard to Heal Wounds

Conditions

Hard to Heal Wounds, Venous Leg Ulcers, Diabetic Lower Extremity Ulcers, Traumatic/ Post Operative Wounds

Trial Timeline

Jul 24, 2014 → Jun 4, 2018

NCT ID
NCT02020746

About EscharEx + Gel Vehicle

EscharEx + Gel Vehicle is a phase 2 stage product being developed by MediWound for Hard to Heal Wounds. The current trial status is completed. This product is registered under clinical trial identifier NCT02020746. Target conditions include Hard to Heal Wounds, Venous Leg Ulcers, Diabetic Lower Extremity Ulcers.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02020746Phase 2Completed

Other Products from MediWound

NexoBrid + Gel VehiclePhase 3
69
NexoBridPhase 3
69
EscharEx (EX-03) + Placebo (Gel vehicle)Phase 3
69
DGDPhase 3
69
EscharEx (5% EX-02 formulation) + Gel Vehicle + Non-surgical standard of care (NSSOC)Phase 2
44